Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Background It remains unclear why radiation clinically provides a synergistic effect when combined with immune checkpoint inhibitors such as nivolumab. The purpose of our study was to retrospectively evaluate whether the therapeutic efficacy of nivolumab is improved as a result of a history of radio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley 2019-04-01
Saila:Thoracic Cancer
Gaiak:
Nivolumab
NSCLC
PD‐1
radiotherapy
synergistic effect
Sarrera elektronikoa:https://doi.org/10.1111/1759-7714.13044
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak